Find News

Filter articles

Applied Filters

Showing 91 to 100 of 232 results

GSK triumphs in trademark suit in India


Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India.

Sun Pharma to acquire Ocular Technologies for $40m


India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million.

Astellas to acquire Ganymed for €422m

Germany, Japan31-10-2016

Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.

Sunovion Pharmaceuticals acquires Cynapsus for $653m

Canada, Japan, US26-10-2016

Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.

Novartis wins growth hormone domain dispute


Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center.

Sun Pharma collaborates with ICGEB to develop dengue vaccine


Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets.

Janssen sells five drugs for $155m


India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash.

AstraZeneca to divest Rhinocort Aqua rights outside US


AstraZeneca and Cilag, an affiliate of Johnson & Johnson, have entered into an agreement for AstraZeneca to divest the rights to Rhinocort Aqua outside the US.

$2m worth of fake drugs seized in Myanmar


Myanmar authorities have seized K2.8 billion worth of counterfeit and expired drugs.

Glenmark partners with Particle Sciences in Abraxane generic deal


India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services.

Showing 91 to 100 of 232 results